Resminostat (4SC-201) in Relapsed or Refractory Hodgkin's Lymphoma
Clinical trial NCT01037478 · COMPLETED
Trial details
- NCT number
- NCT01037478
- Sponsor
- 4SC AG
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2012-01-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.